EUVIMEDEUVIMED entdecken
Crossref

Higher Serum Aspartate May be Associated with Better Cognitive Function as Mediated by Reduced Aβ Accumulation in Frontal and Temporal Lobes in Mild Cognitive Impairment

Sarraa Ahmad Qahtan, Ali Fawzi Al-Hussainy, Vimal Arora, M M Rekha, Mayank Kundlas, Kattela Chennakesavulu, Mehul Manu, Jasur Rizaev, Sada Ghalib Taher, Mariem Alwan, Mahmood Jawad, Hiba Mushtaq

Journal of Molecular Neuroscience · 2025

DOI: 10.1007/s12031-025-02418-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Neuroscience, 2025. Verfasst von Sarraa Ahmad Qahtan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia Techniques, Health and Medical Techniques College, Alnoor University, Mosul, Iraq. sarraa.ahmad@alnoor.edu.iq. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Aspartic Acid, Amyloid beta-Peptides, Temporal Lobe. Die Arbeit nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aspartate, a key excitatory neurotransmitter, has shown conflicting links to cognitive disorders like Alzheimer's disease (AD) and mild cognitive impairment (MCI). Given its role in brain function, studying its relationship with amyloid-beta (Aβ) accumulation may provide important insights into these conditions. This study is the first to examine the link between serum aspartate levels, Aβ accumulation in key brain regions, and cognitive function (via ADAS-Cog) across cognitively normal (n = 113), MCI (n = 283), and AD (n = 24) participants. The results showed significant increases in Aβ accumulation across all brain regions from CN to MCI and AD groups (overall p < 0.001; pairwise p ≤ 0.001). In individuals with MCI, elevated aspartate levels were inversely associated with Aβ accumulation in the frontal (β = - 0.122, p = 0.041) and temporal regions (β = - 0.128, p = 0.032), but this relationship was lost after adjusting for age, gender, education, handedness, and ApoE ɛ4, ɛ3, and ɛ2 genotypes. Further analysis identified age and ApoE ɛ4, ɛ3 status as key modifiers of the aspartate-Aβ relationship in MCI. Mediation analysis revealed that higher serum aspartate levels were associated with better cognitive function, potentially mediated by reduced Aβ accumulation in the frontal (β = - 0.037) and temporal lobes (β = - 0.043) in MCI, but this effect disappeared after adjusting for demographic factors and ApoE genotypes. Overall, higher serum aspartate levels may be associated with reduced Aβ accumulation and improved cognitive outcomes in MCI, with age and ApoE genotypes acting as key confounders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionAspartic AcidAmyloid beta-PeptidesTemporal LobeAlzheimer DiseaseFrontal LobeCognitionHumansMaleFemaleAgedAged, 80 and overApolipoproteins EMiddle Aged

Stichwörter der Autor:innen

Alzheimer’s diseaseAmyloid-beta (Aβ)AspartateAβ accumulationBrain functionCognitive impairment

Substanzen

Aspartic AcidAmyloid beta-PeptidesApolipoproteins E

Autor:innen und Institutionen

  • Department of Anesthesia Techniques, Health and Medical Techniques College, Alnoor University, Mosul, Iraq. sarraa.ahmad@alnoor.edu.iq.
  • College of Pharmacy, Ahl Al Bayt University, Kerbala, Iraq.
  • University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India.
  • Department of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to Be University), Bangalore, Karnataka, India.
  • Centre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, 140401, Punjab, India.
  • Department of Chemistry, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.

Zitieren

APA

Qahtan, S. A., Al-Hussainy, A. F., Arora, V., Rekha, M. M., Kundlas, M., Chennakesavulu, K., Manu, M., Rizaev, J., Taher, S. G., Alwan, M., Jawad, M., & Mushtaq, H. (2025). Higher Serum Aspartate May be Associated with Better Cognitive Function as Mediated by Reduced Aβ Accumulation in Frontal and Temporal Lobes in Mild Cognitive Impairment. Journal of Molecular Neuroscience. https://doi.org/10.1007/s12031-025-02418-4

Vancouver

Qahtan SA, Al-Hussainy AF, Arora V, Rekha MM, Kundlas M, Chennakesavulu K, et al. Higher Serum Aspartate May be Associated with Better Cognitive Function as Mediated by Reduced Aβ Accumulation in Frontal and Temporal Lobes in Mild Cognitive Impairment. Journal of Molecular Neuroscience. 2025. doi:10.1007/s12031-025-02418-4

BibTeX
@article{Qahtan2025,
  author = {Qahtan, Sarraa Ahmad and Al-Hussainy, Ali Fawzi and Arora, Vimal and Rekha, M M and Kundlas, Mayank and Chennakesavulu, Kattela and Manu, Mehul and Rizaev, Jasur and Taher, Sada Ghalib and Alwan, Mariem and Jawad, Mahmood and Mushtaq, Hiba},
  title = {Higher Serum Aspartate May be Associated with Better Cognitive Function as Mediated by Reduced Aβ Accumulation in Frontal and Temporal Lobes in Mild Cognitive Impairment},
  journal = {Journal of Molecular Neuroscience},
  year = {2025},
  doi = {10.1007/s12031-025-02418-4}
}
Kostenlos starten →